(Date:5/13/2008)... electronic bingo to fulfill the unmet needs of ...nities, SACRAMENTO, Calif., May 13 /PRNewswire/ -...unced its formation to advocate for the use of,tra...go as a responsible,legal and consistent funding ...ions for this new alliance include Disabled Sports...
(Date:5/13/2008)...ion Among 52 Companies Recognized for Promoting ...GROVE, Minn., May 13 /PRNewswire/ -- The National ...ganization of large employers, today,honored Data ...nd,dedication to promoting a healthy workplace and... and families., (Logo: http://www.newscom.com/cg...
(Date:5/13/2008)...ntal revenue increase 12.0 percent demonstrating ...om reporting for first time since separation; stra...ng results, - Management updates financial guidanc... and operational momentum, BATESVILLE, In...ings,Inc. (NYSE: HRC ), reporting for the first ...
(Date:5/13/2008)... Highlights, - Third quarter fiscal 2008 reve... in the same quarter last year. - On ...for Dietary Supplement Manufactur...swire-FirstCall/ -- Natural,Alternatives Internati...mulator, manufacturer and marketer of customized n...
Breaking Medicine News(10 mins):Health News:Charities Form Alliance to Preserve and Improve Charity Bingo 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 2Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 4Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 5Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 6Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 7Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 8Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 9Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 10Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 11Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 12Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 13Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 14Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 2Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 3Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 4Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 5...rms that some people are much more sensitive to pa...ing patients' descriptions of their pain. "One of...een having confidence in the accuracy of patients'...ll, an assistant professor of neurobiology and ana...
... diet is a simple recipe for good health. Harvard ...ks found that those consuming the classic diet -- ...getables and accompanied by a moderate amount of w...."The closer you are to adhering to this diet, the...
...niversity shows cholesterol-lowering effects from ...e study is the first placebo-controlled clinical t...s of tea in humans. Studies of large populations h...fits that include lower levels of LDL, or bad, cho...
...rvations about pregnancy is that births are someti...fter major weather events, such as hurricanes or s...den changes in barometric pressure that precede a ...earch has proved any such link. Air pressure chang...
Other Medicine News:Health News:Eat Like a Greek for Good Health 2(Date:5/12/2008)... ChloraPrep(R) Products Expand Infection Prevent...rstCall/ -- Cardinal Health, a,global provider of ...productivity of health care, today announced it ha... held Enturia, Inc., the manufacturer of,infection...brand name., ChloraPrep(R) brand products are use...
(Date:5/12/2008)...mmune cells adjust their function like a radio dia...nts at how autoimmune disease may develop,late in ...wire/ -- A St. Jude Children,s,Research Hospital s...regulators, do not use simple on/off switches to g...development and function. Rather, they,possess sop...
(Date:5/12/2008)...ntation of Phase 1 Clinical Data of MDX-1100 at Di... 2008, PRINCETON, N.J., May 12 /PRNewswire-Fir...d today that it has initiated the Phase 2 clinical...noclonal antibody that,targets CXCL10 (also known ...id arthritis (RA). MDX-1100 could potentially trea...
(Date:5/9/2008)...ANGKOK, Thailand, May 9 /PRNewswire-USNewswire/ --...ty for the Protection of Animals (WSPA),is on stan...ne struck,Myanmar to assess and then relieve the s...ors depend on for food and their livelihoods., ...Agriculture,Organization of the United Nations (FA...
Breaking Medicine Technology:Cardinal Health Completes Enturia Acquisition 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4Animals That Cyclone Survivors Depend on Need Help Now 2Rice Nanyang Tech collaborate on sustainable nanoelectronics 357 1Rice Nanyang Tech collaborate on sustainable nanoelectronics 357 2Rice Nanyang Tech collaborate on sustainable nanoelectronics 357 3TriWest Creates First of its Kind Partnership to Offer Military Leaders With Grief Support Program 518 1TriWest Creates First of its Kind Partnership to Offer Military Leaders With Grief Support Program 518 2Dana Corporation Inc Enters Into Settlement Agreement With Dana Retiree Committee 516 1Dana Corporation Inc Enters Into Settlement Agreement With Dana Retiree Committee 516 2Wildlife Sightings on the Rise in California 514 1Wildlife Sightings on the Rise in California 514 2Wildlife Sightings on the Rise in California 514 3...YVALE, Calif. and LOS ANGELES, April 18, 2007,/PRN...nounced data,from two preclinical studies, one ide...one deacetylase (HDAC) inhibitor and,another demon...Bruton,s tyrosine kinase (BTK) inhibitor compounds...ion for Cancer Research (AACR),2007 Annual Meeting...
...GTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - EPIX,...ay positive,cognitive function results from its Ph...RX-07034, the company,s,internally-discovered, nov...lzheimer,s disease and cognitive impairment associ...lind, placebo-controlled Phase 1b,multiple ascend...
Other Medicine Technology:Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 2EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 3EPIX Pharmaceuticals Announces Statistically Significant Results in,Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug,Candidate 4...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: